NIH-funded research NIH-funded research

Understanding lasting oxycodone cravings

Official title: Cellular and circuit adaptations contributing to the incubation of oxycodone craving

Funded at North Central College · NIH-11159750 · Data updated 2026-11-12

This research looks at why cravings for oxycodone can last a long time after someone stops using it, and explores new ways to help reduce these cravings.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorth Central College
NIH-funded
Lab location1 site (Naperville, United States)
Project startAugust 15, 2024
Project endJune 30, 2028
Funding year2025
Award (this year)$159,443
NIH project number5R16DA062584-02
Project IDNIH-11159750 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is currently conducted in animal models, so it does not involve direct patient participation at this stage.

Less likely to help

Patients not experiencing oxycodone addiction or long-lasting cravings would not directly benefit from this particular research.

What this research studies

Many people struggling with opioid addiction face long-lasting cravings, making it hard to stay sober. This project aims to understand the brain changes that cause these intense cravings for oxycodone to grow stronger over time, even after someone has stopped using the drug. Researchers are exploring how certain brain cell connections, specifically involving AMPA receptors, adapt in ways that contribute to these persistent cravings. They are also testing if a medication like ketamine, given during withdrawal, could help reverse these brain changes and reduce the intensity of cravings.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that help reduce the intense, long-lasting cravings experienced by people recovering from oxycodone addiction.

How similar studies have gone: Previous studies have shown similar brain changes with other drugs of abuse, and there is growing interest in ketamine as a potential treatment for substance use disorders.

Where this research is happening

  • North Central College
    Naperville, United States
    Active

Researchers

  • Principal investigator: Stefanik, Michael Thomas — North Central College
  • Study coordinator: Stefanik, Michael Thomas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.